CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

AIM2-driven inflammasome activation in heart failure H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems Histopathologic validation of the intravascular ultrasound diagnosis of calcified coronary artery nodules Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE

Original Research2021 Jun 12;cvab202.

JOURNAL:Cardiovasc Res. Article Link

AIM2-driven inflammasome activation in heart failure

Z Onódi, M Ruppert, D Kucsera et al. Keywords: canakinumab; cardiomyopathy; drug repurposing; heart failure; inflammation; probenecid

Full Text PDF